Informing the Marketplace to Support a Successful Pharmaceutical Market Entry
CHAPEL HILL, N.C. – September 9, 2011. The pharmaceutical marketplace is rapidly changing with new medicines and therapeutic approaches pushing innovation across almost every aspect of the development spectrum. And while it’s still essential for companies with new products to educate the marketplace for maximum market entry, how that’s accomplished is evolving with companies’ pipelines and marketplace practices.
With this in mind, Best Practices, LLC has published a report to inform launch leaders on:
- Identification of Key Education Tactics for Thought Leaders, Physicians, Patients, and Payers
- Identification of Key Timing for Educational Activities for KOLs, Physicians, Patients and Payers
- Assessment of Key Market Education Practices, including Thought Leader Activities, CME, Scientific Publication Strategy and Tactics, Patients and Patient Advocacy Education, Clinical Trials & Payer Education
- Description of Critical Market Education Pitfalls and Future Trends
Executives and managers involved in market education efforts for new products can use this research to compare their market education tactics and strategies with those of leading organizations.
The report, Educating KOLs, Physicians, Patients and Payers to Support Successful Product Launches, contains a plethora of benchmark metrics on the most effective physician, payer and patient education practices conducted from clinical development through launch. The 139-page report contains almost 500 metrics to help inform launch leaders on the most effective type and timing of market education practices during the full development cycle.
The research project attracted 34 executives and managers from 26 leading pharmaceutical, biotech and medical device companies including 12 of the Top 20 pharma companies. Additionally, the research reflects on nine deep-dive interviews with selected participants.
Download a complimentary report summary, including sample best practices drawn from extensive primary research with executives at leading companies at: http://www.best-in-class.com/rr1114.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC’s clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.